Skip to main content

Amplion Biomarker Engine

Amplion has launched a biomarker engine, a proprietary platform to rapidly and accurately gather, filter, and annotate biomarker information. The platform uses natural language processing and machine learning, and is able to gather and filter large volumes of biomarker information from diverse sources, said Amplion in a statement. It is being used initially to expand the coverage of biomarkers in clinical trials in BiomarkerBase.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.